Allied healthcare products inc (AHPI)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10
Cash flows from operating activities:
Net loss

-330,484

-1,531,484

-614,123

-474,162

378,479

-779,427

-1,234,575

-143,204

-901,037

-380,693

-767,236

-494,389

-403,242

-374,699

-816,336

-282,043

-784,466

-708,764

-529,558

-521,094

-503,291

-44,750

-708,175

-347,727

-968,712

-898,915

-590,559

-97,967

-279,081

-468,693

-411,032

-156,362

-145,786

22,690

-144,968

114,726

60,323

117,114

-87,755

Adjustments to reconcile net loss to net cash provided (used in) by operating activities:
Depreciation and amortization

139,408

142,081

180,785

186,200

200,139

216,626

219,103

227,723

227,723

235,409

240,553

247,692

279,471

280,218

282,745

289,390

307,251

313,876

317,968

322,547

321,437

332,434

334,693

333,959

330,773

311,089

304,975

314,276

341,389

343,033

307,346

335,104

320,867

320,530

306,848

290,703

317,949

376,515

376,517

Stock based compensation

529

564

793

792

791

774

740

738

739

708

645

645

644

623

579

579

579

736

1,052

1,051

1,052

1,260

1,593

1,552

1,528

1,620

4,955

10,965

10,804

11,004

11,424

11,293

11,191

11,408

10,287

4,333

4,269

4,633

7,026

Provision for doubtful accounts and sales returns and allowances

23,061

-4,438

3,000

-529

12,180

7,012

986

-6,994

-6,200

-14

1,090

-65

-38

-374

11,015

234

-235

2,427

433

6,797

27,242

14,590

13,248

11,858

871

7,522

-1,399

-5,022

-1,660

15,580

1,474

13,547

-3,552

15,129

1,901

-

-

-

-

Provision for doubtful accounts and sales returns and allowances

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

5,525

14,188

Deferred tax provision

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

414,052

0

-1

-123,906

0

0

0

0

-74,836

0

0

-277,910

-338

-748,390

-4,402

-4,569

-35,531

-213,292

-4,562

-4,116

47,603

-1,708

-1,853

-2,810

Changes in operating assets and liabilities:
Accounts receivable

736,619

-252,655

17,136

-259,611

19,852

220,289

-543,585

9,928

151,159

139,316

73,034

-77,953

173,417

54,461

-871,411

-48,805

421,141

180,281

-29,970

-171,310

509,861

-282,717

-132,388

-147,931

378,007

-122,502

-597,587

652,234

-118,533

-136,181

-1,138,771

783,200

-91,398

-920,012

-218,032

58,717

1,064,317

-1,387,124

213,559

Inventories

-675,848

144,013

19,951

-560,350

-244,024

-414,209

721,137

-572,014

-703,633

-27,725

621,959

-107,509

-231,486

-208,337

184,016

-167,019

-55,955

-124,719

32,052

-192,356

-236,182

51,735

161,616

-886,478

-171,352

218,236

907,349

-386,941

-324,300

-291,539

339,897

-336,777

-734,730

320,676

198,768

-661,722

-208,922

469,024

-200,547

Income tax receivable

0

6,175

100

-8,120

0

200

7,920

-9,938

2,428

6,233

900

-8,875

2,578

894

5,403

-11,286

1,579

250

9,525

-16,596

1,493

-201

10,625

-21,904

-465

-8,985

11,754

36,766

-583,706

281,762

255,902

46,042

-169,507

-18,221

92,150

-681,003

-34,766

-53,682

-12,636

Other current assets

68,641

-40,348

38,801

-45,363

67,477

12,447

-40,258

-5,769

12,882

-88,517

16,331

70,254

29,346

-192,544

152,911

-60,954

-36,017

-68,936

92,862

-71,401

-150,033

70,428

69,666

-51,874

-134,354

-10,620

185,968

-

-

-

-

-

-

-

-

-

-

-

-

Other assets, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-89,722

-68,025

257,430

-176,659

161,425

47,964

242,270

-43,020

19,130

21,154

-5,359

Accounts payable

-203,352

324,634

100,449

-364,237

-50,103

-146,487

556,441

-166,329

-439,784

510,924

128,404

-38,693

114,870

-436,506

-63,871

-597,804

489,323

393,965

210,322

-30,220

191,800

-330,536

469,531

-799,182

176,124

-4,384

378,462

4,129

-380,808

-141,071

37,808

209,053

-439,890

231,246

151,825

-336,404

-142,096

-63,094

236,058

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-114,700

-172,050

-172,050

-172,050

-172,050

-172,050

-172,050

-172,050

-172,050

Other accrued liabilities

133,601

841,571

-311,933

299,069

-18,655

-126,032

89,247

35,798

164,468

-716,863

357,314

323,515

-51,777

-329,123

-273,851

-142,563

413,588

-300,764

211,375

-18,541

430,867

-282,202

405,257

-337,075

-96,693

-69,002

265,715

-

-

-

-

-

-

-

-

-

-

-

-

Other accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-58,447

-151,139

257,385

-

605,431

-492,662

315,578

-344,043

316,075

-334,437

-253,303

Net cash provided by (used in) operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

95,292

-285,401

-16,783

212,203

343,968

-148,449

406,628

-103,264

-627,945

-728,199

-423,245

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) operating activities

1,808,082

-84,257

-717,017

470,379

748,496

-646,261

-513,272

552,239

-416,927

-243,450

-751,454

191,989

-33,927

-514,335

-330,638

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

370,678

-

797,129

501,322

150,149

929,037

-456,988

882,981

122,854

Cash flows from investing activities:
Capital expenditures

18,776

2,382

26,005

0

0

0

0

-

-

-

-

0

9,551

2,895

8,602

0

0

73,982

25,318

0

55,078

36,925

49,163

59,286

126,776

64,900

187,542

470,718

250,583

377,072

269,161

624,738

673,208

414,136

498,858

222,736

25,193

53,192

47,430

Net cash used in investing activities

-18,776

-2,382

-26,005

0

0

0

0

-

-

-

-

0

-9,551

-2,895

-8,602

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-269,161

-

-673,208

-414,136

-498,858

-218,736

-25,193

-53,192

-47,430

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-73,982

-25,318

0

-55,078

-36,925

-49,163

-59,286

-126,776

-64,900

-187,542

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows from financing activities:
Borrowings under revolving credit agreement

7,632,934

7,964,244

8,626,876

7,800,583

7,207,900

9,027,498

8,140,086

7,748,637

7,025,454

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments under revolving credit agreement

8,618,724

7,828,458

7,776,872

8,211,318

8,153,832

8,048,791

7,762,126

8,431,409

6,342,682

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-985,790

135,786

850,004

-410,735

-945,932

978,707

377,960

-682,772

682,772

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

45,341

70,889

0

Net increase (decrease) in cash and cash equivalents

803,516

49,147

106,982

59,644

-197,436

332,446

-135,312

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

265,845

-243,450

-751,454

-

-43,478

-517,230

-339,240

-30,091

95,292

-359,383

-42,101

212,203

288,890

-185,374

357,465

-162,550

-754,721

-793,099

-610,787

-639,489

-258,923

-799,729

101,517

-1,090,742

123,921

87,186

-348,709

710,301

-436,840

900,678

75,424